After the course, participants will be able to: 

1. Explain the purpose, principles, and uses of HTA in medicine and health technology access, health policy, health financing and the broader UHC;

2. Describe the Philippine HTA and medicine access landscape, including relevant institutions, processes, and stakeholder roles;

3. Identify the major HTA evidence domains: clinical, economic, budget impact, ethical/legal/social, equity, and health system considerations; and

4. Interpret basic economic evaluation and budget impact concepts at a decision-maker level. 

After the course, participants are expected to be capable of:

1. Mapping the access pathways for health technologies, identifying relevant institutions, decision points, and stakeholder roles;

2. Developing a decision-relevant HTA question and preliminary scope using PICOT and the appropriate analytical perspective;

3. Developing an evidence readiness matrix covering clinical, economic, budget impact, ethical, legal, social, equity, patient, implementation, and health system considerations; 

4. Critically appraising clinical, economic, and budget-impact evidence using appraisal tools; and

5. Developing a public access strategy for health technologies.

1. Overview of HTA: Rationale, Principles, History, and experiences in other countries

2. HTA in the Philippine Health System and UHC Framework

3. HTA Process: From Topic Identification to Recommendation

4. Clinical and Safety Assessment for Non-Specialists

5. Economic Evaluation, Costing, and Budget Impact

6. Ethical, Legal, Social, Equity, and Health System Considerations

7. From HTA Recommendation to Access, Reimbursement, and Implementation

8. Applied HTA Case Workshop and Synthesis  

Madeleine de Rosas-Valera, MD, MScIH

Dr. Madeleine de Rosas-Valera is an accomplished public health expert with over 30 years of experience in public healthcare administration, health financing, and communicable and non-communicable disease (NCD) prevention and control. She was the Former Undersecretary of the Department of Health (2012-2013), Senior Vice President of Philhealth (1999-2010) and Technical Officer for Health System and Patient safety of WHO, Western Pacific Region.

Dr. Valera graduated from De La Salle Health Sciences Medical School. She had her Master in International Health at Heidelberg University. And, was awarded with a Gustav Nossal Fellow on Health Reform Na Pyle Fellow on Pharmaceutical and Health Insurance Policy at Harvard University. 

John Paul Caesar delos Trinos, MPH, MHM, PhD

Dr. John Paul Caesar R. delos Trinos is a health economist and public health researcher specialising in health technology assessment (HTA), health financing, economic evaluation, and health systems strengthening within the context of Universal Health Care in the Philippines. He is Co-founder and Chief Scientific Officer of metaHealth Insights and Innovations, Chief Researcher of the Newborn Screening Reference Centre, and Professorial Lecturer in Health Economics and HTA at the De La Salle Medical and Health Sciences Institute. He completed his PhD and dual master’s degrees in Health Economic Evaluation and Health Leadership and Management at the University of New South Wales. His work spans HTA, benefit package development, costing, economic evaluation, and evidence generation for government, multilateral, academic, and industry stakeholders.

Diana Beatriz Bayani, MSc, PhD

Dr. Diana Bayani is an Engagement Manager at Vista Health Singapore, specializing in HTA submissions across the Asia–Pacific region. She brings over a decade of international, multi-sector experience in research, policy formulation, consulting, and teaching in HEOR. Before moving to Singapore, she led the HTA Study Group the Philippine Department of Health, and developed benefit packages for PhilHealth. She is trained in health economics, epidemiology and biostatistics with degrees from the National University of Singapore, the London School of Economics and Political Science, and the London School of Hygiene and Tropical Medicine.

Veronica Prasad, MD, MSc

Dr. Veronica Prasad is a public health professional and physician with over a decade of experience spanning healthcare management, health economics, and pharmaceutical policy. She holds a Master of Science in Public Health (Health Economics Track) from the London School of Hygiene & Tropical Medicine. Experienced in academic research, evidence synthesis, and the design of data-informed interventions for better health outcomes. Adept at translating complex evidence into actionable strategies for health policy and practice.